Description
Nasal Research Line — Mitochondrial-Derived Peptide (Intranasal)
A pre-mixed MOTS-C nasal spray referenced in intranasal peptide-delivery research.
Key research areas
- Nasal-mucosa absorption of small mitochondrial-derived peptides in the literature
- AMPK-pathway engagement via non-injection delivery in preclinical research
- Mitochondrial-encoded peptide research in animal intranasal-delivery studies
- Comparative pharmacokinetics vs. subcutaneous administration research
Mechanism
MOTS-C is a 16-amino-acid mitochondrial-encoded peptide referenced in AMPK-pathway engagement research. Research describes its ~2,174 Da molecular weight as sitting within the range referenced in nasal-mucosa absorption research. The literature characterises intranasal peptide delivery as an alternative research route that bypasses first-pass metabolism, with the pre-mixed format designed for standard nasal-spray research protocols.
For in-vitro laboratory research only. Not for human consumption.
Specs
| Field | Details |
|---|---|
| Molecular weight | ~2,174 Da |
| Sequence | 16 amino acids |
| Purity | ≥98% HPLC |
| Format | Pre-mixed nasal spray |
| Molecular Weight | 1419.53 Da |
| Size | 10mg per 10ml bottle |
Before you purchase
Ships pre-mixed. Refrigerate between uses.
For research use only. All products supplied strictly for in-vitro laboratory research and not intended for human consumption. Not evaluated by the TGA or FDA. Any observations described are drawn from published research only. Purchasers confirm they are 18+ and using for legitimate research purposes.
